20 completed, 4 unknown, 2 terminated, 1 not yet recruiting. 9 Phase 3, 8 Phase 2, 6 Not applicable, 4 Phase 1, 3 Phase 4.
Follow Lice Infestations: new trials by email Literature Review of Lice Infestations trials Research Report on Lice Infestations
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Efficacy and Preventative Effect of a Head Lice Product (X92001483) vs. Nix Creme Rinse (1% Permethrin). Medical Device (X92001483) - Lice; Head Lice | Not applicable | Recruiting | Oystershell NV | 98 | 2026-05-01 | 2026-06-22 |
| Efficacy and Safetyof a Medical Device With a Physical Mode of Action (X92001919) Versus Paranix Anti-lice Shampoo. Pulverize (X92001919), Paranix Anti-Lice Shampoo - Lice; Head Lice | Not applicable | Not yet recruiting | Oystershell NV | 34 | 2026-02-01 | 2025-11-24 |
| Comparison Effectiveness of Oral Ivermectin , 1% Permethrin Shampoo and 4% Dimeticone Liquid Gel in the Treatment of Pediculosis Capitis Among School Children in Chachoengsao Province, Thailand Oral Ivermectin, 4% dimenticone liquid gel - Pediculus Capitis Infestation, Permethrin Adverse Reaction | Phase 4 | Unknown | Phramongkutklao College of Medicine and Hospital | 117 | 2023-12-15 | 2024-03-27 |
| A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation Vamousse Spray 'n' Go, Nix Creme Rinse Lice Treatment - Pediculosis Capitis, Lice Infestations | Phase 4 | Completed | Alliance Pharmaceuticals | 58 | 2022-12-15 | 2025-02-24 |
| Comparison of Oral Ivermectin and Permethrin 5% Lotion in Treatment of Pediculosis Capitis Permethrin 5% topical lotion, Ivermectin - Pediculosis | Phase 1 | Completed | Combined Military Hospital Abbottabad | 60 | 2022-03-01 | 2022-12-09 |
| Comparative Head Lice Therapy With Dimet 5® vs. Hedrin® Once Dimet 5 - Head Lice Infestation, Pediculosis Capitis | Unknown | Infectopharm Arzneimittel GmbH | 240 | 2021-05-17 | 2024-03-06 | |
| Treatment of Pediculosis (Head Lice) in Senegal Ivermectin Oral Product - Pediculoses | Not applicable | Completed | Institut de Recherche pour le Developpement | 450 | 2018-07-11 | 2019-02-27 |
| A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5% Ivermectin Lotion, 0.5%, SKLICE (ivermectin) Lotion, 0.5%, Vehicle of the Test product - Lice; Head Lice | Phase 1 | Completed | Sun Pharmaceutical Industries, Inc. | 413 | 2017-03-20 | 2018-05-18 |
| Effectiveness of "No More" Anti-lice Medical Device to Kill Lice and Lice Eggs Topically - Lice | Not applicable | Unknown | Pharmayeda | 50 | 2015-10-01 | 2015-10-07 |
| Efficacy and Safety Study for PIOLIN® Shampoo PIOLIN®, NEDAX - PEDICULOSIS | Phase 3 | Unknown | Phytopharm Consulting Brazil | 212 | 2014-07-01 | 2013-10-23 |
| Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers Ha44, Ha44 Placebo, Moxifloxacin Placebo - Pediculosis | Phase 1 | Completed | Dr. Reddy's Laboratories Limited | 57 | 2012-01-01 | 2021-07-09 |
| Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation spinosad - Pediculosis | Phase 4 | Completed | ParaPRO LLC | 26 | 2011-09-01 | 2012-11-22 |
| An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation Group A - Low-Dose Ha44 0.37% w/w, Group B - High Dose Ha44 Gel 0.74% w/w, Group C - Placebo - Pediculosis | Phase 2 | Completed | Dr. Reddy's Laboratories Limited | 142 | 2011-04-01 | 2020-04-29 |
| Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice Malathion gel 0.5%, Permethrin 1% rinse (Nix Crème) - Pediculosis | Phase 3 | Completed | Sun Pharmaceutical Industries, Inc. | 403 | 2009-08-01 | 2014-06-13 |
| Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice Malathion gel 0.5%, Permethrin 1% rinse - Pediculosis | Phase 3 | Completed | Sun Pharmaceutical Industries, Inc. | 254 | 2009-08-01 | 2014-08-04 |
| Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice Malathion gel 0.5%, Malathion lotion 0.5% - Pediculosis | Phase 1 | Completed | Sun Pharmaceutical Industries, Inc. | 24 | 2009-07-01 | 2013-12-24 |
| Pediatric Head Lice Study Product Comparison LICEMD, Standard Head lice product - Head Lice | Phase 2 | Completed | Hackensack Meridian Health | 97 | 2009-05-01 | 2016-07-29 |
| Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice MALG (malathion) Treatment - Pediculosis | Phase 2 / Phase 3 | Completed | Sun Pharmaceutical Industries, Inc. | 12 | 2008-09-01 | 2014-08-07 |
| Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice Spinosad, Permethrin 1% - Pediculosis | Phase 3 | Completed | ParaPRO LLC | 558 | 2007-09-01 | 2012-10-11 |
| A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation Placebo, BGC20-0582 - Pediculus Humanus Capitis, Head Lice | Phase 2 | Completed | Boston Scientific Corporation | 230 | 2007-08-01 | 2022-06-28 |
Showing 20 of 28. Sign in to see all of them.
Ancylostomiasis (1) · Ascariasis (1) · Hookworm Infections (1) · Parasitic Diseases (1) · Strongyloidiasis (1) · Trichuriasis (1)
Ectoparasitic Infestations (28) · Infections (28) · Skin Diseases (28) · Skin Diseases, Infectious (28) · Skin Diseases, Parasitic (28) · Skin and Connective Tissue Diseases (28) · Parasitic Diseases (27) · Adenophorea Infections (1) · Ascaridida Infections (1) · Enoplida Infections (1) · Helminthiasis (1) · Nematode Infections (1) · Rhabditida Infections (1) · Secernentea Infections (1) · Strongylida Infections (1)
Ivermectin (5) · Malathion (4) · Permethrin (4) · Suspensions (2) · spinosad (2) · Equipment and Supplies (1) · Hexachlorocyclohexane (1) · Moxifloxacin (1) · Therapeutics (1) · coconut diethanolamide (1)
Sun Pharmaceutical Industries, Inc. (7) · Dr. Reddy's Laboratories Limited (2) · Medical Entomology Centre (2) · Oystershell NV (2) · ParaPRO LLC (2) · Alliance Pharmaceuticals (1) · Boston Scientific Corporation (1) · Centers for Disease Control and Prevention (1) · Combined Military Hospital Abbottabad (1) · Hackensack Meridian Health (1) · Infectopharm Arzneimittel GmbH (1) · Institut de Recherche pour le Developpement (1) · Johnson & Johnson Consumer and Personal Products Worldwide (1) · Larada Sciences, Inc. (1) · Pharmayeda (1)
United States (15) · Israel (2) · United Kingdom (2) · Australia (1) · Brazil (1) · France (1) · Germany (1) · Guatemala (1) · India (1) · Ireland (1) · Pakistan (1) · Senegal (1) · Thailand (1)
Ian F Burgess (2) · Albert Dietz, MD (1) · Ben Berger (1) · Bill Miller, MD (1) · Bushra Muzaffar, FCPS (1) · Byron Arana, MD (1) · Cheikh Sokhna, PhD (1) · Dale Clayton, PhD/Biology (1) · Dowling B Stough, M.D. (1) · Jeffrey Boscamp, MD (1) · Jeffrey C Seiler, M.D. (1) · Jerry Cottrell (1) · Lawrence Rosen, MD (1)
PMID 17845167, PMID 20220184, PMID 21337950, PMID 26092045, PMID 42480517